Zobrazeno 1 - 10
of 86
pro vyhledávání: '"K, Henricson"'
Autor:
Albara Ah Ramli, Xin Liu, Kelly Berndt, Erica Goude, Jiahui Hou, Lynea B. Kaethler, Rex Liu, Amanda Lopez, Alina Nicorici, Corey Owens, David Rodriguez, Jane Wang, Huanle Zhang, Daniel Aranki, Craig M. McDonald, Erik K. Henricson
Publikováno v:
Sensors, Vol 24, Iss 4, p 1123 (2024)
Differences in gait patterns of children with Duchenne muscular dystrophy (DMD) and typically developing (TD) peers are visible to the eye, but quantifications of those differences outside of the gait laboratory have been elusive. In this work, we me
Externí odkaz:
https://doaj.org/article/b7bda2629f9b401dac327d4bef652e0e
Autor:
Albara Ah Ramli, Xin Liu, Kelly Berndt, Chen-Nee Chuah, Erica Goude, Lynea B. Kaethler, Amanda Lopez, Alina Nicorici, Corey Owens, David Rodriguez, Jane Wang, Daniel Aranki, Craig M. McDonald, Erik K. Henricson
Publikováno v:
Sensors, Vol 24, Iss 4, p 1155 (2024)
Estimation of temporospatial clinical features of gait (CFs), such as step count and length, step duration, step frequency, gait speed, and distance traveled, is an important component of community-based mobility evaluation using wearable acceleromet
Externí odkaz:
https://doaj.org/article/470323fcd8644d4390eecfbf7c575be9
Autor:
Abhinandan Batra, Alison M. Barnard, Donovan J. Lott, Rebecca J. Willcocks, Sean C. Forbes, Saptarshi Chakraborty, Michael J. Daniels, Jannik Arbogast, William Triplett, Erik K. Henricson, Jonathan G. Dayan, Carsten Schmalfuss, Lee Sweeney, Barry J. Byrne, Craig M. McDonald, Krista Vandenborne, Glenn A. Walter
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background The lack of dystrophin in cardiomyocytes in Duchenne muscular dystrophy (DMD) is associated with progressive decline in cardiac function eventually leading to death by 20–40 years of age. The aim of this prospective study was to
Externí odkaz:
https://doaj.org/article/4f3246949aea4b8fb84745347438167c
Autor:
Craig M McDonald, Eduardo Marbán, Suzanne Hendrix, Nathaniel Hogan, Rachel Ruckdeschel Smith, Michelle Eagle, Richard S Finkel, Cuixia Tian, Joanne Janas, Matthew M Harmelink, Arun S Varadhachary, Michael D Taylor, Kan N Hor, Oscar H Mayer, Erik K Henricson, Pat Furlong, Deborah D Ascheim, Siegfried Rogy, Paula Williams, Linda Marbán, Russell Butterfield, Anne Connolly, Francesco Muntoni, Nanette C. Joyce, Maya Evans, Mehrdad Abedi, Prasanth Surampudi, Sanjay Jhawar, Jonathan G. Dayan, Colleen Anthonisen, Erica Goude, Alina Nicorici, Omaid Sarwary, Poonam Prasad, Jayoon Baek, Andrew Newton, Hannah Johnson, Kyle Kusmik, Lauri Filar, Angie Edmondson, Irina Rybalsky, Wendy Chouteau, Anthony F. Giordano, Aixa Rodriguez, Kristan Anderson, Germaine Wezel, Melisa Vega, Julie Duke, Jorge Collado, Matthew Civitello, Julie Wells, Erika Pyzik, Rebecca Rehborg, Michelle Brown, Jennifer Van Eyk, Russell G. Rogers
Publikováno v:
The Lancet. 399:1049-1058
Cardiosphere-derived cells (CDCs) ameliorate skeletal and cardiac muscle deterioration in experimental models of Duchenne muscular dystrophy. The HOPE-2 trial examined the safety and efficacy of sequential intravenous infusions of human allogeneic CD
Autor:
Catherine Siener, Marisa Birkmeier, Heather Gordish-Dressman, Erik K Henricson, Tina Duong, Cinrg-Dnhs Investigators, Alicia Fernandez-Fernandez, Craig M. McDonald, Jennifer Canbek, Leslie Nelson
Publikováno v:
Journal of Neuromuscular Diseases
Background: Duchenne muscular dystrophy (DMD) is a rare x-linked recessive genetic disorder affecting 1 in every 5000–10000 [1, 2]. This disease leads to a variable but progressive sequential pattern of muscle weakness that eventually causes loss o
Autor:
Craig M, McDonald, Oscar H, Mayer, Kan N, Hor, Debra, Miller, Nathalie, Goemans, Erik K, Henricson, Jessica R, Marden, Jonathan, Freimark, Henry, Lane, Adina, Zhang, Molly, Frean, Panayiota, Trifillis, Karyn, Koladicz, James, Signorovitch
Publikováno v:
Journal of neuromuscular diseases.
Evidence on the long-term efficacy of steroids in Duchenne muscular dystrophy (DMD) after loss of ambulation is limited.Characterize and compare disease progression by steroid treatment (prednisone, deflazacort, or no steroids) among non-ambulatory b
Autor:
John W. Day, Mar Tulinius, Alan Pestronk, Tina Duong, Tulio E. Bertorini, Alberto Dubrovsky, Nanette C. Joyce, Anne M. Connolly, Hanna Kolski, Lauren P. Morgenroth, Hoda Abdel-Hamid, Ksenija Gorni, Craig M. McDonald, Erik K Henricson, Erik Landfeldt, Yoram Nevo, Jose Carlo, Sherilyn W. Driscoll, Laura McAdam, S. Chidambaranathan, Paula R. Clemens, Avital Cnaan, Jean Teasley, W. Douglas Biggar, Joel Iff, Andrew J. Kornberg, Nancy L. Kuntz, E. Henricson, Jean K. Mah, Carolina Tesi-Rocha, Robert T. Leshner, Mathula Thangarajh, Richard D. Webster, V. Vishwanathan, Monique M. Ryan, John B. Bodensteiner, Timothy Lotze, Richard T. Abresch, Peter I. Karachunski
Publikováno v:
Value Health
OBJECTIVES: The objective of this study was to examine the psychometric properties of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL 4.0 GCS) in Duchenne muscular dystrophy (DMD), a rare, severely debilitating, and ultimately
Autor:
Perry B Shieh, Gary Elfring, Panayiota Trifillis, Claudio Santos, Stuart W Peltz, Julie A Parsons, Susan Apkon, Basil T Darras, Craig Campbell, Craig M McDonald, Richard J Barohn, Enrico Bertini, Kate Bushby, Brigitte Chabrol, Emma Ciafaloni, Jaume Columer, Giacomi Pietro Comi, Anne Connolly, Richard S Finkel, Kevin M Flanigan, Nathalie Goemans, Michela Guglieri, Susan T Iannaccone, Kristi J Jones, Petra Kaufmann, Janbernd Kirschner, Jean K Mah, Katherine Mathews, Eugenio Mercuri, Francesco Muntoni, Yoram Nevo, Andrés Nascimento Osorio, Yann Péréon, Rosaline Quinlivan, J. Ben Renfroe, Barry Russman, Monique Ryan, Jacinda Sampson, Ulrike Schara, Kathryn Selby, Thomas Sejersen, Douglas M Sproule, H. Lee Sweeney, Már Tulinius, Juan J Vilchez, Giuseppe Vita, Thomas Voit, Stephanie Burns-Wechsler, Brenda Wong, Ted Abresch, Erik K Henricson, Kim Coleman, Michelle Eagle, Julaine Florence, Ed Gappmaier, Craig McDonald, Hoda Z Abdel-Hamid, Clemens Bloetzer, Russell J Butterfield, Jong-Hee Chae, Jahannaz Dastgir, Isabelle Desguerre, Raul G Escobar, Erika Finanger, Peter Heydemann, Imelda Hughes, Anna Kaminska, Peter Karachunski, Martin Kudr, Timothy Lotze, Alexandra Prufer de Queiroz Campos Araujo, Maria Bernadete Dutra de Resende, Gihan Tennekoon, Haluk Topaloglu, Ricardo Erazo Torricelli, Lindsay N Alfano, Meredith K James, Linda Lowes, Anna Mayhew, Elena S Mazzone, Leslie Nelson, Kristy J Rose
Publikováno v:
Paediatrics Publications
Aim: Compare efficacies of deflazacort and prednisone/prednisolone in providing clinically meaningful delays in loss of physical milestones in patients with nonsense mutation Duchenne muscular dystrophy. Materials & methods: Placebo data from Phase I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e773db882a9b68ac18148646fe6a8d7
https://ir.lib.uwo.ca/context/paedpub/article/3206/viewcontent/843.pdf
https://ir.lib.uwo.ca/context/paedpub/article/3206/viewcontent/843.pdf
Autor:
Abhinandan Batra, Alison M. Barnard, Donovan J. Lott, Rebecca J. Willcocks, Sean C. Forbes, Saptarshi Chakraborty, Michael J. Daniels, Jannik Arbogast, William Triplett, Erik K. Henricson, Jonathan G. Dayan, Carsten Schmalfuss, Lee Sweeney, Barry J. Byrne, Craig M. McDonald, Krista Vandenborne, Glenn A. Walter
Publikováno v:
BMC cardiovascular disorders, vol 22, iss 1
Background The lack of dystrophin in cardiomyocytes in Duchenne muscular dystrophy (DMD) is associated with progressive decline in cardiac function eventually leading to death by 20–40 years of age. The aim of this prospective study was to determin
Autor:
Craig M. McDonald, Heather Gordish-Dressman, Erik K. Henricson, Tina Duong, Nanette C. Joyce, Sanjay Jhawar, Mika Leinonen, Fengming Hsu, Anne M. Connolly, Avital Cnaan, Richard T. Abresch, A. Dubrovsky, A. Kornberg, M. Ryan, R. Webster, W.D. Biggar, L.C. McAdam, J.K. Mah, H. Kolski, V. Vishwanathan, S. Chidambaranathan, Y. Nevo, K. Gorni, J. Carlo, M. Tulinius, T. Lotze, T.E. Bertorini, J.W. Day, P. Karachunski, P.R. Clemens, H. Abdel-Hamid, J. Teasley, N. Kuntz, S. Driscoll, J.B. Bodensteiner, A.M. Connolly, A. Pestronk, R.T. Abresch, E.K. Henricson, N.C. Joyce, C.M. McDonald, A. Cnaan, L.P. Morgenroth, R. Leshner, C. Tesi-Rocha, M. Thangarajh, T. Duong
Publikováno v:
Neuromuscular Disorders. 28:897-909
We describe changes in pulmonary function measures across time in Duchenne muscular dystrophy patients treated with glucocorticoids (GCs) 1 year compared to GC naïve patients in the Cooperative International Research Group Duchenne Natural History S